Capecitabine Hand-Foot Syndrome Triggers Sharp Quality-of-Life Decline at Grade Two
A secondary analysis of breast cancer clinical trial data shows that quality-of-life deterioration accelerates sharply once capecitabine-induced hand-foot syndrome advances ...

